Walvax Biotechnology Co Ltd
SZSE:300142
Walvax Biotechnology Co Ltd
Cash from Financing Activities
Walvax Biotechnology Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
W
|
Walvax Biotechnology Co Ltd
SZSE:300142
|
Cash from Financing Activities
¥236.6m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-16%
|
Beigene Ltd
HKEX:6160
|
Cash from Financing Activities
-¥448.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Financing Activities
¥2.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Financing Activities
-¥893.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-98%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Financing Activities
-¥2.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-39%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Financing Activities
-¥374.2m
|
CAGR 3-Years
-104%
|
CAGR 5-Years
-98%
|
CAGR 10-Years
N/A
|
See Also
What is Walvax Biotechnology Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
236.6m
CNY
Based on the financial report for Dec 31, 2023, Walvax Biotechnology Co Ltd's Cash from Financing Activities amounts to 236.6m CNY.
What is Walvax Biotechnology Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-16%
Over the last year, the Cash from Financing Activities growth was 150%. The average annual Cash from Financing Activities growth rates for Walvax Biotechnology Co Ltd have been 3% over the past three years , -20% over the past five years , and -16% over the past ten years .